The broad range of national experience held by HBM4EU partners will contribute a diversity of skills and solid expertise to training and capacity activities. We will generate added value in terms of increased scientific excellence, through an exchange of expertise, including training to promote the use of common methods and protocols. In this way, the HBM4EU will promote the adoption of best practice in HBM activities across Europe.

The HBM4EU training programme includes both basic courses, targeted courses, workshops, and train-the-trainer sessions, as well as capacity building for PhD students. The programme is being developed on the basis of a survey of needs of HBM4EU partners, matched against available training capacities and is intended to serve the HBM4EU partners. Certain events may be made open to external participants, on the basis of availability.

Up coming HBM4EU trainings

Workshop on Results on the HBM4EU’s chromate occupational study

“Cr(VI) is a carcinogen to which people may be exposed in the workplace. Although Cr(VI) compounds are subject to authorisation under Regulation (EC 1907/2006) concerning the Registration, Evaluation, Authorisation and Restriction  of Chemicals (REACH), these compounds are still widely used in different applications, especially in surface treatment of different metallic objects. In addition, workers may be exposed to Cr(VI) formed during hot processes, such as welding.

HBM4EU chromate study evaluated the occupational exposure to Cr(VI) in surface treatment activities and welding in eight different countries in Europe. The study included approximately 40 companies and in total of almost 580 workers and control subjects.  Research brief of the study is available here.

The first results of the study are presented in this webinar targeted specifically to industry, workers representatives, regulatory agencies and policy makers. The specific objectives of the webinar are:

  • Inform on the results of the HBM4EU Chromate study.
  • Give recommendations to workplaces on the monitoring of CrVI exposure.
  • Provide information that support policy action.
  • Support the science to policy framework.

Program here.

To registhttp://d-policy-makers_agenda.pdfer click here.